Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of N-13 Ammonia PET Myocardial Perfusion Imaging
NCT03275584Phase 4Recruiting
- Sponsor
- Centre hospitalier de l’Université de Montréal
- Start
- Jan 2018
- Primary completion
- Jan 2028
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ammonia n-13 in coronary artery disease (CAD), sponsored by Centre hospitalier de l’Université de Montréal. Started Jan 2018; status: recruiting.
02
Drugs
ammonia n-13
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT03275584.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03275584.